TY - JOUR
T1 - Up-regulation of acetylcholine receptors during subchronic infusion of pancuronium is caused by a posttranscriptional mechanism related to disuse
AU - Fink, Heidrun
AU - Yasuhara, Shingo
AU - Blobner, Manfred
AU - Martyn, J. A.Jeevendra
PY - 2004/2
Y1 - 2004/2
N2 - Objective: Contrasting with the classic theory that competitive block of the acetylcholine receptor induces up-regulation of the receptor, recent studies show that irreversible block of acetylcholine receptors with α-bungarotoxin decreases acetylcholine receptor number within hours. This study investigated the early effects of competitive acetylcholine receptor block with the reversible, competitive muscle relaxant, pancuronium. Design: Prospective, randomized, placebo-controlled experimental study. Subjects: Healthy adult Sprague-Dawley rats. Setting: Animal laboratory in a university hospital. Interventions: After internal review board approval, Sprague-Dawley rats were anesthetized and received pancuronium at a rate to completely suppress neuromuscular twitch. The control group received saline. Infusion times were 0, 3, 6, or 12 hrs (n = 8 per group). One sciatic nerve was stimulated to induce muscle twitch, and the other nerve remained unstimulated. Total acetylcholine receptor expression, as well as expression of messenger RNA of the five subunits, was assayed. Measurements and Main Results: There were no differences in acetylcholine receptor number between groups at time points 0, 3, and 6 hrs. At 12 hrs, acetylcholine receptor numbers in both the stimulated (35.2 ± 4.8 fmol acetylcholine receptor/mg protein) and nonstimulated (38.3 ± 4.8) pancuronium group, as well as the nonstimulated control saline group (37.5 ± 4.6), were significantly increased compared with stimulated controls (27.6 ± 4.0). Pancuronium did not potentiate the acetylcholine receptor upregulation of the nonstimulated control group at 12 hrs. There were no changes in messenger RNA expression between groups. Conclusions: Infusion of the reversible competitive inhibitor pancuronium up to 12 hrs does not reduce acetylcholine receptor number and therefore contrasts with the irreversible acetylcholine receptor blocker α-bungarotoxin. This study documents that 12 hrs of disuse per se leads to an increased expression of the acetylcholine receptor number by a posttranscriptional mechanism that can be prevented by nerve-evoked muscle contraction.
AB - Objective: Contrasting with the classic theory that competitive block of the acetylcholine receptor induces up-regulation of the receptor, recent studies show that irreversible block of acetylcholine receptors with α-bungarotoxin decreases acetylcholine receptor number within hours. This study investigated the early effects of competitive acetylcholine receptor block with the reversible, competitive muscle relaxant, pancuronium. Design: Prospective, randomized, placebo-controlled experimental study. Subjects: Healthy adult Sprague-Dawley rats. Setting: Animal laboratory in a university hospital. Interventions: After internal review board approval, Sprague-Dawley rats were anesthetized and received pancuronium at a rate to completely suppress neuromuscular twitch. The control group received saline. Infusion times were 0, 3, 6, or 12 hrs (n = 8 per group). One sciatic nerve was stimulated to induce muscle twitch, and the other nerve remained unstimulated. Total acetylcholine receptor expression, as well as expression of messenger RNA of the five subunits, was assayed. Measurements and Main Results: There were no differences in acetylcholine receptor number between groups at time points 0, 3, and 6 hrs. At 12 hrs, acetylcholine receptor numbers in both the stimulated (35.2 ± 4.8 fmol acetylcholine receptor/mg protein) and nonstimulated (38.3 ± 4.8) pancuronium group, as well as the nonstimulated control saline group (37.5 ± 4.6), were significantly increased compared with stimulated controls (27.6 ± 4.0). Pancuronium did not potentiate the acetylcholine receptor upregulation of the nonstimulated control group at 12 hrs. There were no changes in messenger RNA expression between groups. Conclusions: Infusion of the reversible competitive inhibitor pancuronium up to 12 hrs does not reduce acetylcholine receptor number and therefore contrasts with the irreversible acetylcholine receptor blocker α-bungarotoxin. This study documents that 12 hrs of disuse per se leads to an increased expression of the acetylcholine receptor number by a posttranscriptional mechanism that can be prevented by nerve-evoked muscle contraction.
UR - http://www.scopus.com/inward/record.url?scp=1242297558&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000109445.38396.F5
DO - 10.1097/01.CCM.0000109445.38396.F5
M3 - Article
C2 - 14758171
AN - SCOPUS:1242297558
SN - 0090-3493
VL - 32
SP - 509
EP - 513
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 2
ER -